Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2024-11-02 06:20:53| The Economic Times

Next week the primary market anticipates the IPO of Swiggy, along with four other offerings. Included are Acme Solar Holdings, Sagility India, and Niva Bupa Healthcare. Neelam Linens will debut in the SME segment. Swiggy aims to utilize IPO proceeds for investment in subsidiary Scootsy, technology, cloud infrastructure, and brand marketing.


Category: News and Media

 

Latest from this category

27.01Instagram, Facebook and WhatsApp to trial premium subscriptions
27.01BFSI outlook remains strong despite near-term NIM pressures: Gaurang Shah
27.01Rupee recovers 10 paise from all-time low to 91.80 against US dollar in early trade
27.01Selling stocks to buy gold and silver ETFs? Why turning a hedge into a bet can backfire
27.01Silver soars 6%, gold up over 1% to scale new peak and this may just be the start. Check where the bullion is headed now
27.01Axis Bank shares surge over 4% as Q3 PAT rises 3% YoY. Should you buy now?
27.01Waaree Renewable Technologies shares in focus after approval to acquire 55% stake in ASPL for Rs 1,225 crore
27.01Why owning sector leaders could be a smarter core bet in 2026, Axis Mutual Funds Karthik Kumar explains
News and Media »

All news

27.01Instagram, Facebook and WhatsApp to trial premium subscriptions
27.01BFSI outlook remains strong despite near-term NIM pressures: Gaurang Shah
27.01Tuesday Watch
27.01Rupee recovers 10 paise from all-time low to 91.80 against US dollar in early trade
27.01Selling stocks to buy gold and silver ETFs? Why turning a hedge into a bet can backfire
27.01Silver soars 6%, gold up over 1% to scale new peak and this may just be the start. Check where the bullion is headed now
27.01Axis Bank shares surge over 4% as Q3 PAT rises 3% YoY. Should you buy now?
27.01Waaree Renewable Technologies shares in focus after approval to acquire 55% stake in ASPL for Rs 1,225 crore
More »
Privacy policy . Copyright . Contact form .